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Abstract
Meningococcal carriage dynamics drive patterns of invasive disease. The distribution of
carriage by age has been well described in Europe, but not in the African meningitis belt, a
region characterised by frequent epidemics of meningitis. We aimed to estimate the age-spe-
cific prevalence of meningococcal carriage by season in the African meningitis belt. We
searched PubMed, Web of Science, the Cochrane Library and grey literature for papers report-
ing carriage of Neisseria meningitidis in defined age groups in the African meningitis belt. We
used a mixed-effects logistic regression to model meningococcal carriage prevalence as a func-
tion of age, adjusting for season, location and year. Carriage prevalence increased from low
prevalence in infants (0.595% in the rainy season, 95% CI 0.482–0.852%) to a broad peak
at age 10 (1.94%, 95% CI 1.87–2.47%), then decreased in adolescence. The odds of carriage
were significantly increased during the dry season (OR 1.5 95% CI 1.4–1.7) and during out-
breaks (OR 6.7 95% CI 1.6–29). Meningococcal carriage in the African meningitis belt peaks
at a younger age compared to Europe. This is consistent with contact studies in Africa, which
show that children 10–14 years have the highest frequency of contacts. Targeting older
children in Africa for conjugate vaccination may be effective in reducing meningococcal
transmission.
Introduction
Most transmission of Neisseria meningitidis occurs amongst carriers; therefore vaccinating
carriers is the only way to generate herd protection. Experience with conjugate vaccines has
shown that with the correct age-specific strategy, such indirect effects make a profound con-
tribution to disease control [1]. To this end, it is important to understand the distribution of
meningococcal carriage to allow for efficient targeting of individuals who account for the most
transmission. The age distribution of meningococcal carriers in industrialised countries has
been described and synthesised; this showed that prevalence peaks around 19 years of age
[2]. Patterns of carriage are however known to differ in the African meningitis belt, a region
that experiences the highest burden of meningococcal disease in the world. Meningococcal
carriage is a common occurrence compared to invasive disease, although the overall prevalence
is highly variable, ranging from 0% to 30% [3,4]. Although the distribution of carriage preva-
lence by age also appears more variable in the African meningitis belt than in high-income
countries, some studies have shown that carriage is most prevalent in children [3].
Studies of meningococcal carriage in the African meningitis belt have identified a number
of risk factors apart from age. A multi-site cross-sectional study found increased odds of men-
ingococcal carriage in rural areas vs. urban and higher prevalence in males [4]. Household
crowding and pollution from tobacco and indoor kitchen facilities also increased the odds
of carriage significantly [4]. The association between respiratory infection and meningococcal
carriage remains unclear, but some studies indicate a positive relationship between carriage
acquisition and symptoms of respiratory disease, like sore throat or rhinitis [5]. Localised epi-
demics of meningococcal meningitis occur frequently in the belt, but there is no clear relation-
ship between epidemic status and the prevalence of carriage. One study found higher rates of
serogroup W carriage in a district experiencing a group W epidemic compared to a neighbour-
ing non-epidemic district, prompting speculation that it may be dominance of a strain rather
than overall prevalence that links carriage and epidemics [6].
Season is an important risk factor for carriage in the African meningitis belt. Meningitis
epidemics in the meningitis belt occur in the dry season and mathematical models of menin-
gococcal transmission dynamics currently require substantial ‘seasonal forcing’ of transmission
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to reproduce the observed patterns of disease [7]. One study
found higher odds of carriage of capsular meningococci during
the dry season; [4] this has not been demonstrated consistently
but is compatible with the idea that the capsule protects the bac-
terium from drying during aerosol transmission. Carriage of
unencapsulated strains does not appear to have any association
with season [4].
Previous reviews of the literature on meningococcal carriage in
Africa have not been systematic in nature and have not examined
age-specific patterns in any quantitative way. The aim of this
paper was to conduct a systematic literature review of meningo-
coccal carriage prevalence by age and season in the African men-
ingitis belt and to synthesise these data in order to inform future
vaccination strategies.
Methods
Search and study selection
This paper was prepared in accordance with the meta-analysis of
observational studies in epidemiology (MOOSE) and PRISMA
guidelines [8,9]. The literature searches were performed by one
author (LVC) in January 2017 and updated in September 2017.
PubMed, Web of Science, the Cochrane Library and the grey lit-
erature were searched for papers reporting carriage of N. menin-
gitidis in defined age groups in locations within the African
meningitis belt, using the following search terms: ‘(‘Neisseria
meningitidis’ OR ‘N meningitidis’ OR meningitis OR meningo-
coccal OR meningococci OR meningococcus OR meningitidis)
AND (carriage OR carrier OR carriers) AND (Africa OR ‘menin-
gitis belt’ OR Gambia OR Senegal OR Guinea-Bissau
OR Mauritania OR Guinea OR Ghana OR ‘Burkina Faso’ OR
‘Upper Volta’ OR ‘Cote d’Ivoire’ OR ‘Ivory Coast’ OR Togo
OR Benin OR Nigeria OR Niger OR Chad OR Tchad OR
Cameroon OR ‘Central African Republic’ OR Sudan OR ‘South
Sudan’ OR Eritrea OR Ethiopia OR Uganda OR Kenya OR
‘Democratic Republic of Congo OR Zaire)’.
Studies were eligible for inclusion if they reported pharyngeal
carriage of all meningococcal serogroups in defined age groups
in generalisable populations in the African meningitis belt.
Longitudinal, cross-sectional and serial cross-sectional study
designs were included. Studies reporting carriage rates among
household contacts of Hajjis or other known carriers were
excluded. Studies in both English and French were included in
the systematic review. Two studies in Russian were excluded
because abstracts could not be obtained. The reference lists of
included papers were hand-searched to identify any papers that
were missed by the electronic search.
Data extraction and classification
We contacted authors for additional information if studies
reported age groups wider than 10 years and the median age
was not reported or if the time period of the study was not
reported. Where carriage prevalence was reported in age groups
of range 10 years or less, we used the midpoint age for analysis.
For open-ended age groups, we calculated a midpoint with an
upper age limit of 60 years. Using additional data from the
African Meningococcal Carriage Consortium cross-sectional
studies, we divided the oldest age group previously reported as
30 plus years into two groups, 30–44 years and 45 plus years.
For papers that included results from several populations or
studies, data were extracted only for observations meeting the
inclusion criteria. Extracted data included the study location,
time period, design, any mention of an outbreak or epidemic of
meningitis coinciding with the study period, whether the study
occurred before or after the MenAfriVac mass campaigns in the
study region, use of random sampling, laboratory used to culture
the pharyngeal swabs, time between sampling and plating, age
range of the individuals, median age of individuals in each
age group, number of individuals swabbed and the number of
individuals positive for capsulated meningococcal carriage. We
excluded individuals carrying capsule-null isolates from our def-
inition of capsulated meningococcal carriage but isolates charac-
terised as non-determinate or non-groupable were included.
Studies were assigned to the dry or rainy season on the basis of
the month in which the study took place, defining the dry season
as December–June and the rainy season as July–November.
Additional data from the studies by Kristiansen and colleagues
in Burkina Faso and Ethiopia were used to divide prevalence esti-
mates from these studies into dry and rainy season measures.
Studies were classified as having used random sampling if this
was specifically reported; otherwise ‘no’ was recorded.
Data were extracted independently by LVC and AK and differ-
ences were checked by CLT.
Data analysis
For the meta-analysis, we excluded data from age bands wider
than 20 years. For longitudinal studies, only the first observation
in the time series was used to avoid over-representing a particular
population in the meta-analysis.
A natural cubic spline (a piecewise cubic polynomial function
with linear tails) was used to model group median age [2,10]. The
basis matrix for the spline was generated using the ‘ns()’ function
in the R core package ‘splines’. Boundary knots (points in the
spline below and above which the function is defined to be linear)
were placed at 0 and 30 years because of the low density of sam-
pling in older age groups. The number of internal knots was
selected by comparing the AIC of models with two and three
internal knots, placing knots at appropriate quantiles (inner ter-
tiles for two knots, inner quartiles for three knots. Optimal place-
ment of these knots was determined by evaluating the AIC of
models with every possible combination of knots drawn from
the set of ages equidistant from every consecutive observed age
between 0 and 30 years. Internal knots placed at 9.25, 9.75 and
28.5 years of age gave the best model fit.
We modelled season and outbreak status as a three-tiered fixed
effect and a nested interaction term of location and year of swab-
bing as random effects. We used fixed effects for factors that had a
constant effect in all studies and random effects for factors for
which only a subset of all possible levels had been observed. We
tried using the physical laboratory as a proxy for differences in
ambient temperature, growth medium, swab type and other unre-
ported factors which might affect the likelihood of isolating men-
ingococci from a sample, but this did not improve model fit.
Other factors that were considered but did not improve model
fit included mass group A conjugate vaccination, country, decade,
latitude, time to plating and study.
We started with a simple logistic regression because this is the
traditional model for analysing prevalence data. However, when
we found that a low proportion of observations fell within the
bootstrapped 95% CI, we investigated three additional models
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which are commonly used to capture overdispersion: an
observation-level random effects model, a beta-binomial or hier-
archical model and a zero-inflated binomial model [11]. We
found that the simple logistic regression captured more of the
variability in the data than the observation-level random effects
model and provided a better fit than the beta-binomial and
zero-inflated binomial models, so we used a logistic structure
for our final model.
All candidate models allow overall carriage prevalence to vary
but constrain the distribution of prevalence by age to be the same
across all years and locations.
Models were fit using the lme4, spaMM and glmmADMB
packages in R [12–15]. To generate confidence intervals for the
model predictions and random effects, 10 000 iterations of boot-
strapping with replacement were performed and bias-corrected
95% confidence intervals were calculated [16]. Profile confidence
intervals for fixed effects parameters were calculated using the
lme4 package [12]. We assessed model fit by AIC and by per-
forming leave-one-out cross-validation, whereby the model is
refit on the full dataset excluding a single observation and this
new model is used to predict prevalence in the excluded observa-
tion. This prediction is then compared to the true value. To check
the results of the spline model, we identified the age group with
the highest carriage prevalence for each study measuring carriage
in more than one age group and performed a one-way proportion
test between this peak value and prevalence in all other age
groups. To adjust for repeated significance testing, we used an
upper P-value cut-off of 0.0005, yielding an overall confidence
of >95%.
We checked our season definition against average monthly
rainfall anomalies in each site using publicly available data from
the National Oceanic and Atmospheric Administration
(Fig. S1). In a sensitivity analysis, we excluded data from four
sites with non-characteristic rainfall patterns. These sites all fell
on the edges of the meningitis belt: Butajira, Ethiopia (2 sub-
sites), Arba Minch, Ethiopia (4 sub-sites) and Kpalkpalgbeni,
Bring-Ahafo District, Ghana.
For the visual presentation of the fixed-effects portion of the
model, we adjusted the observed carriage prevalence (Pobserved)
to account for the random effects in the full model as follows:
Padjusted = exp(log (Pobserved)-σLocation-σLocation-year), where σLocation
and σLocation -year are the random effects intercept for location
and year for a given observation.
To estimate the proportion of carriers that would be targeted
in a mass vaccination campaign covering four age groups (0–15
years, 0–17 years, 0–19 years and 0–29 years) we assumed a
population structure consistent with that of Niger in 2017 and
used the fitted estimate of carriage prevalence for the rainy season
(although results are consistent across seasons) [17]. We
accounted for uncertainty in this estimate by simulating 100 000
draws from a uniform distribution with boundaries at the 2.5th
and 97.5th percentile of the fitted prevalence, using these draws
as the rates for a random binomial draw with population size cor-
responding to each single year age cohort in Niger 2017 and then
taking the 2.5th and 97.5th percentiles of the proportion covered to
yield a 95% confidence interval.
Assessment of study quality and heterogeneity
We assessed the role of study design by comparing a model with
and without sampling procedure (random vs. non-random) and
with and without time to plating of swabs as fixed-effect variables.
Role of the funding source
The sponsor of the study had no role in study design, data collec-
tion, data analysis, data interpretation, or writing of the report.
The corresponding author had full access to all the data in the
study and had final responsibility for the decision to submit for
publication.
Results
We identified 23 relevant articles that reported unique studies of
carriage by age in generalisable populations in the African men-
ingitis belt representing eight countries: Burkina Faso, Chad,
Ethiopia, Ghana, the Gambia, Mali, Nigeria and Niger. Eleven
were cross-sectional studies; five serial cross-sectional, four longi-
tudinal and three were vaccine trials (two polysaccharide and one
conjugate vaccine). Twelve of 23 articles did not report random-
isation in participant selection. Sixteen studies were eligible for
inclusion in the meta-analysis (Table 1). Seven of these 16 did
not report random sampling. Eighteen of 23 studies in the system-
atic review and 15 of 16 eligible for inclusion in the meta-analysis
reported information on the serogroups or genogroups of the car-
riage isolates (Table 2). See Figure 1 and Tables S1 and S2 for fur-
ther details of search and reasons for exclusion.
Systematic review
Longitudinal studies
Longitudinal studies reported high variation in carriage rates over
time (1–35%), but no significant differences in carriage prevalence
between age groups, probably because of smaller sample sizes
[18–21]. Prevalence recorded around the time of meningococcal
outbreaks was high in recent studies (2000s and 2010s), with
two studies showing particularly high rates in ages 5–29 years
(16–38%) [22–24]. Two early studies (1970s) of carriage during
a single group A meningococcal outbreak found lower rates of
carriage (2–5%) [25,26].
Studies of seasonal change
Most studies which specified months comprising the dry and
rainy seasons placed the beginning of the dry season between
November and January and the beginning of the rainy season
between April and July. One study also included a Harmattan sea-
son (October–January) between the rainy and dry seasons [27].
Early studies documented the variability of carriage prevalence
in the African meningitis belt but found little support for consist-
ent differences in prevalence by season. A year-long study in
Burkina Faso found a wide variation in carriage rates but no sig-
nificant changes associated with the onset of the rainy season
[21]. Two other studies found similarly variable results with no
obvious seasonal patterns [27,28]. One study in rural northern
Nigeria displayed remarkably stable prevalence over the year,
with carriage ranging from 2.1% to 2.7% at four sampling inter-
vals [28]. These early studies may have been limited by their rela-
tively short duration or small sample sizes.
An 8-year longitudinal study of a cohort (n∼ 300) in Northern
Ghana measured carriage twice annually, in April and November.
Although this was not noted in associated publications, the aver-
age carriage rate in November (4.4%) was substantially lower than
that in April (7.9%) [18]. This was the first study to produce evi-
dence supporting the hypothesis that carriage prevalence
increases during the dry season.
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A multi-site serial cross-sectional study in Burkina Faso meas-
uring carriage four times annually in 2009 and 2011 found signifi-
cantly higher carriage prevalence in dry season surveys than in
rainy [29,30]. Finally, a serial cross-sectional study across seven
countries of the meningitis belt found significantly elevated
odds of carriage during the dry season as compared with the
rainy (adjusted OR, 1.54; 95% CI, 1.37–1.75) [4].
Laboratory methods
All studies relied on culture for the initial identification of men-
ingococcal isolates. Between one and ten colonies were selected
for further testing, most commonly serogrouping. Fourteen of
23 studies (all published after 2000) reported using molecular
methods for confirmation and further characterisation of culture
isolates.
Meta-analysis
Data from 16 papers, comprising 114 331 individual swabs, were
available for quantitative data synthesis.
The four model variants tested did not vary greatly in their
parameter estimates and goodness of fit (Table S3). We selected
the simple logistic regression model because the greatest propor-
tion of observations fell within the 95% confidence interval of
bootstrapped predictions and the leave-one-out cross-validation
Table 1. Carriage studies included in meta-analysis. Summary of studies of meningococcal carriage by age in the African meningitis belt included in meta-analysis
Paper Location
Study
period Study design Study population Ages
Burian et al., 1974
[35]
Bamako, Mali Jan–May
1970
Cross-sectional School children, children seen
at preventative care centers,
contacts of cases
All ages
Blakebrough
et al., 1980[25]
Malumfashi, Nigeria Dec 1977
to Jun
1978
Cross-sectional School children 5–10
Blakebrough
et al., 1983[26]
Malumfashi, Nigeria Jan–May
1978
Vaccine trial School children (boys), both
controls and polysaccharide
vaccines
11–20
Leimkugel et al.,
2007[18]
Navrongo, Ghana Apr 1998
to Nov
2005
Longitudinal General All ages
Amadou Hamidou
et al., 2006[19]
Niamey, Niger Feb–May
2003
Longitudinal School children 7–16
Yaro et al., 2007
[20]
Bobo-Dioulasso, Burkina Faso Feb–Jun
2003
Longitudinal General 4–29
Forgor et al., 2005
[23]a
Kpalkpalgbeni, Ghana Apr 2003
to Apr
2004
Serial
cross-sectional
General All ages
Mueller et al.,
2011[22]
Ouagadougou, Burkina Faso Mar 2006 Cross-sectional General 1–39
Trotter et al., 2013
[36]
Bobo-Dioulasso, Burkina Faso Mar 2008 Cross-sectional General 0–59
Kristiansen et al.,
2011[29]
Bogodogo, Dande and Kaya, Burkina Faso Feb–Nov
2009
Serial
cross-sectional
General 1–29
Basta et al., 2013
[37]
Bamako, Mali; Butajira, Ethiopia; Niakkar, Senegal;
Say, Niger
Jun 2009
to Jan
2010
Cross-sectional School children 5–15
MenAfriCar
Consortium 2015
[4]
Bamako, Mali; Narena and Siby, Mali; Butajira,
Ethiopiaa; Fatick, Senegal; Niakkar, Senegal;
Kassena-Nankana, Ghana; Navrongo, Ghana;
Konduga, Nigeria; Maiduguri, Nigeria; Mandelia,
Chad; N’Djamena, Chad; Say, Niger; Yantala, Niger
Apr 2010
to Jul
2012
Serial
cross-sectional
General All ages
Kristiansen et al.,
2013[30]
Bogodogo, Dande and Kaya, Burkina Faso Oct 2010
to Nov
2011
Serial
cross-sectional
General 1–29
Kristiansen et al.,
2014[33]
Bogodogo, Dande and Kaya, Burkina Faso Oct–Nov
2012
Cross-sectional General 1–29
Manigart et al.,
2016[38]
Fajikunda, the Gambia Jul 2013 Cross-sectional General 10–18
Bårnes et al., 2016
[39]a
Arba Minch, Ethiopia Mar–Sep
2014
Cross-sectional General 1–29
aObservations excluded in sensitivity analysis–climactic outlier sites.
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correlation was greatest for this model. This best-fitting model had
season as a fixed effect and location and year as random effects.
The fixed effects parameters of the final model are shown in
Table 3. The model suggests that meningococcal carriage preva-
lence in the African meningitis belt increases rapidly in child-
hood, peaks at 10 years of age (1.94% in the rainy season, 95%
CI 1.87–2.47%) and gradually declines after this point (Fig. 2).
In a country with the same population structure as Niger, our
model estimates that 58% of carriers are under the age of 16
and 84% are under the age of 30 (Table 4). Odds of carriage
were significantly increased for studies taking place during the
dry season (1.5 95% CI 1.4–1.7) as compared with the rainy sea-
son and further increased for studies taking place during out-
breaks (OR 6.7 95% CI 1.6–29), though the uncertainty in the
latter estimate is high as limited data on carriage during outbreaks
are available. No other risk factors were found to significantly
impact the odds of carriage.
Predicted carriage prevalence by age is shown in Figure 2,
incorporating only fixed effects.
One-way proportion testing between peak reported carriage
prevalence and prevalence in all other age groups confirmed
age-related trends, with four of 13 studies showing a peak in
age groups containing 10 years of age (the peak age identified
by the spline regression model) and the remaining nine showing
no significant difference between peak prevalence and the preva-
lence in the age group containing 10 years of age (Table S4).
Predicted carriage prevalence was not significantly different
when excluding data from sites that were climactic outliers
(Table 3, Figure S3).
Location and year contributed to substantial variation in over-
all carriage rates. Random effects intercepts are given in Tables S5
and S6. Figure S2 shows model predictions including random
effects. The variance for the location-year interaction intercept
was greater than that for the location intercept (1.02 vs. 0.55).
Neither location nor year alone was a consistent determinant of
the location-year intercept (Table S6).
Shown in Figure 3, leave-one-out cross-validation predicted
values were moderately correlated with true values (Pearson’s
rho 0.89). However, the median percent error for non-zero values
was substantial, 34%. The model performed poorly at predicting
observations of 0% carriage. More than half of all observations
were outside the 95% confidence intervals for the model predic-
tions (64%).
Discussion
We found that meningococcal carriage rates in the African men-
ingitis belt were significantly higher in individuals aged 5–19 than
Table 2. Meningococcal serogroup distribution. Summary of the serogroup distribution of N. meningitidis isolated from carriers in the African meningitis belt
Study Year of data collection Prevalence of carriage
Serogroup distribution
A C W X Y NG
Burian 1974[35] 1970 144/2569 (5.6%) 19% 1% … 9% 4% 56%
Sanborn 1971[40]a,d 1971 179/311 (57.6%) 52% … … … … …
Blakebrough 1980[25]d 1977 7/130 (5.4%) 43% … … … … …
Blakebrough 1983[26]d 1978 4/168 (2.4%) 50% … … … … …
Leimkugel 2007[18] 1998 14/300 (4.7%) 57% … 7% 0% 29% 7%
Raghunathan 2006[6]a 2002 203/899 (22.6%) 0% 1% 65% 6% … 28%
Amadou-Hamidou 2006[19] 2003 38/287 (13.2%) 0% … 34% … 11% 55%
Forgor 2005[23]b,d 2003 48/299 (16.1%) … … 71% … … …
Yaro 2007[20] 2003 16/456 (3.5%) … … 50% 0% 0% 50%
Mueller 2011[22] 2006 129/615 (21%) 74% … … … 26% …
Sié 2008[24]a,d 2006 24/180 (13%) 92% … … … … …
Trotter 2013[36] 2008 12/1037 (1.2%) … … 25% 8% 42% 25%
Kristiansen 2011[29] 2009 809/20 326 (4%) 10% 0% 9% 11% 56% 13%
Kristiansen 2013[30] 2010 1643/25 520 (6.4%) 0% 0% 6% 75% 13% 5%
MenAfriCar Consortium 2015[4]b 2010 896/48 405 (1.9%) 5% 3% 69% 2% 7% 11%
Kristiansen 2014[33] 2012 390/4964 (7.9%) 0% 6% 87% 8% 3% 2%
Manigart 2016[38]c 2013 33/999 (3.3%) 0% 6% 33% 0% 9% 30%
Bårnes 2016[39]b 2014 492/7479 (6.6%) 0% 1% 6% 14% 2% 76%
All meta-analysis 1970–2014 4703/114 331 (4.1%) 5% 1% 26% 31% 17% 17%
Pre-MenAfriVac 1970–2014 2637/73 202 (3.6%) 10% 2% 25% 9% 23% 27%
Post-MenAfriVac 2010–2012 2066/41 129 (5.0%) <1% <1% 27% 59% 9% 4%
aExcluded from meta-analysis.
bClimactic outliers excluded from meta-analysis in sensitivity analysis.
cTwo group E and five group B carriers also reported.
dPercentages do not sum to 100 because full serogroup data not reported.
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in age groups outside this range. A logistic regression showed that
carriage prevalence increases from a minimum in infants to a
broad peak in children centered at age 10 (1.94% in the rainy sea-
son, 95% CI 1.87–2.47%), then gradually decreases in later adoles-
cence and adulthood. The trends in prevalence by age captured by
the model are broadly consistent with contact studies in the
sub-Saharan Africa, which find the highest intensity of contacts
in 5–15-year-olds, especially close physical contacts and contacts
with individuals outside of the household [41]. In the context of
future strategies for use of the pentavalent meningococcal conju-
gate vaccine, this work shows that a substantial proportion of
meningococcal carriers could be targeted while lowering the
Fig. 1. Selection of studies on meningococcal carriage prevalence for systematic review and meta-analysis. For full details of all the papers that were reviewed,
including reasons for exclusion, please contact the corresponding author.
Table 3. Fixed effects parameters. Predicted odds ratios and profile confidence intervals and median bootstrapped odds ratios and 95% bootstrapped confidence
intervals for fixed effects parameters from fit on full dataset and on dataset excluding climactic outliers
Factor
Full dataset Excluding climactic outliers
Odds ratio
(95% profile CI)
Odds ratio
(95% bootstrap CI)
Odds ratio
(95% profile CI)
Odds ratio
(95% bootstrap CI)
Natural cubic spline of age
Spline I 3.4 (2.9–4.1) 3.5 (2.5–4.6) 3.6 (3–4.4) 3.7 (2.6–4.9)
Spline II 2 (1.6–2.4) 2 (1.5–2.9) 1.8 (1.4–2.2) 1.8 (1.3–2.6)
Spline III 5.2 (3.7–7.2) 4.9 (3–9.6) 4.9 (3.5–7.1) 4.7 (2.8–9.7)
Spline IV 0.79 (0.71–0.87) 0.79 (0.66–0.93) 0.7 (0.63–0.79) 0.71 (0.59–0.83)
Season
Rainy 1.0 1.0 1.0 1.0
Dry 1.5 (1.4–1.7) 1.5 (1.3–1.8) 1.6 (1.5–1.8) 1.6 (1.3–1.9)
Outbreak 6.7 (1.6–29) 7.9 (3.9–8.3) 4.9 (0.81–31) 5.7 (1.3–6.4)
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upper threshold for vaccination from 29 years of age to 17 or 19
years of age. However, we note that 17% of carriers in the data
that informed our model carried non-groupable strains, which
would not be targeted by a pentavalent vaccine.
The dry season in the African meningitis belt is characterised
by low humidity, high temperatures, increased wind speed and
high levels of airborne dust. We found that the odds of carriage
were significantly increased during the dry season and further
increased during outbreaks, all of which occurred during the
dry season. This is consistent with mathematical modelling
which has shown that seasonal forcing in transmissibility of
carriage is necessary to reproduce the extreme variability
and scale of meningitis incidence characteristic of the African
meningitis belt [7]. This finding is also consistent with in vivo
studies in mice and in vitro studies of human neutrophils
which have shown that exposure to dust is associated with
Fig. 2. Observed carriage prevalence measures and model predictions. Top panel: Circles show the data points included in the meta-analysis, with the larger circles
representing a larger sample size. Solid line shows model predictions including random effects. Shaded ribbon shows 95% bias-corrected confidence intervals.
Bottom panel: Circles show the data points included in the meta-analysis, with carriage prevalence adjusted for random effects intercept. Solid line shows
model predictions excluding random effects. Shaded ribbon shows 95% bias-corrected confidence intervals. Dry season predictions are shown in red; rainy season
in blue; outbreak in green.
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reduced bacterial killing and increased bacterial load in the
nasopharynx [31].
However, it is important to emphasise that the increased odds
of carriage during the dry season and during outbreaks are not
sufficient to fully account for the dramatic increase in disease inci-
dence observed during these periods. There is evidence that indi-
vidual susceptibility to invasive disease also increases during the
dry season and during outbreaks [32].
Mass group A conjugate vaccination has no significant effect
on overall carriage prevalence in the model. Serogroup A menin-
gococci accounted for just 10% of all carriage isolates in pre-
vaccine studies (Table 2), so it is not surprising that the model
did not capture any change due to vaccine-related reductions in
group A carriage. Carriage of group A meningococci did substan-
tially decrease from 0.4% overall before mass campaigns to
<0.005% overall after.
This model has some limitations. Cross-validation predictions
are well correlated with true prevalence (Pearson’s rho 0.89), but
substantial variability in carriage prevalence remains unexplained,
with fewer than half of observations falling within the 95% confi-
dence intervals for model predictions.
The model is principally informed by two large serial cross-
sectional studies carried out between 2009 and 2012, one based
in Burkina Faso (50 810 subjects) [29,30,33] and the multi-
country African Meningococcal Carriage Consortium study (48
405 subjects) [4]. These are both high-quality characteristic multi-
site studies, but this dependence may mean that our model is
more representative of recent epidemiological trends in the
African meningitis belt.
Gender was not included in the model because this was not
consistently reported, but the age distribution of carriage may
be modified by gender because of differences in social behaviour
[34]. A number of studies have also shown a higher prevalence of
carriage in males overall, but this would not be expected to bias
the results of this analysis unless the gender distribution of parti-
cipants were substantially different between age groups [4,5].
Because of the sparseness of sampling in older age groups, a
linear relationship between carriage prevalence and age above
30 years was assumed. As a result, carriage appears to decline
steadily throughout middle and later adulthood. However, in real-
ity, carriage may increase in the elderly as immunity wanes.
Further study of this age group will be important as older people
comprise an increasing proportion of the population in the
African meningitis belt.
Despite these shortcomings, we conclude that older children in
African meningitis tend to be the age group in which carriage is
most prevalent. The odds of carriage are significantly higher
during the dry season and during outbreaks and carriage of
group A meningococci has substantially decreased in countries
where mass MenAfriVac vaccination has been implemented.
This meta-analysis may help to guide vaccination policy, both
to maintain control of group A disease and in the implementation
of affordable multivalent vaccines.
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